Johnson & Johnson sold $27k of CVRX
owner at CVRx, Inc.. 2,700 shares at an average of $10.05, traded Nov 21, 2025, filed Nov 25, 2025.
Score components
- +12Role10% owner
- +5Trade size$27k at market
- 0Share of holdings soldSold 0.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -23.1%, 3m -27.5%, 6m -39.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-296047, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2025 | SOpen-market sale Common Stockindirect: By Johnson & Johnson Innovation - JJDC, Inc. | -500 | $10.00 | $5,000 | 4,049,398 | Nov 25, 2025 |
| Nov 24, 2025 | SOpen-market sale Common Stockindirect: By Johnson & Johnson Innovation - JJDC, Inc. | -2,200 | $10.06 | $22k | 4,047,198 | Nov 25, 2025 |
Related signals
Other insiders at CVRx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | CVRx, Inc. | Brent Binkowski CHIEF OPERATING OFFICER | $3,338 1,309 shares | -4% | |
| 46Moderate | CVRXbuy CVRx, Inc. | Brent Binkowski CHIEF OPERATING OFFICER | $76k 26,223 shares | +87% | |
| 10Weak | CVRx, Inc. | Philip B. Adamson Chief Medical Officer | $9,973 1,262 shares | -2% | |
| 27Weak | CVRx, Inc. | Kevin Hykes PRES & CEO | $61k 7,763 shares | -3% | |
| 17Weak | CVRx, Inc. | Jared Oasheim CHIEF FINANCIAL OFFICER | $14k 1,744 shares | -2% | |
| 10Weak | CVRx, Inc. | Paul Verrastro CHIEF MKTG & STRAT OFFICER | $10k 1,284 shares | -2% | |
| 15Weak | CVRx, Inc. | Robert Allen John Chief Revenue Officer | $31k 3,964 shares | -4% | |
| 45Moderate | CVRXbuy CVRx, Inc. | Mudit K. Jain director | $298k 46,800 shares | +5% | |
| 36Weak | CVRXbuy CVRx, Inc. | Mudit K. Jain director | $2,785 600 shares | +12% | |
| 24Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $224k 22,337 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.